Navigation Links
Engineered Viruses Could Battle Superbugs
Date:3/4/2009

Researchers say they disabled bacterial defenses, making antibiotics more effective

WEDNESDAY, March 4 (HealthDay News) -- American researchers say they've engineered a virus that disables the defense systems of bacteria to enhance the effectiveness of antibiotics.

The scientists said this approach could help prevent bacteria from becoming resistant to antibiotics and kill bacteria that have already become antibiotic resistant.

The Massachusetts Institute of Technology and Boston University scientists engineered existing bacteriophages (viruses that infect bacteria) to attack the SOS system -- a bacterial DNA repair system that bacteria use when they're exposed to antibiotics that damage DNA -- and other gene networks in bacteria.

The survival rate for mice infected with bacteria and treated with engineered bacteriophages and antibiotics was 80 percent, compared with 50 percent for mice treated with natural bacteriophages and antibiotics, 20 percent for mice treated with antibiotics alone, and 10 percent for untreated mice.

The study was published in the March 2 online issue of the journal Proceedings of the National Academy of Sciences.

"This work lays the groundwork for the development of a library of bacteriophages, each designed to attack different bacterial targets," lead author Timothy Lu, an M.D. candidate in the Harvard-MIT Division of Health Sciences and Technology, said in an MIT news release.

Antibiotic-resistant bacteria are a serious and growing health threat. For example, methicillin-resistant Staphylococcus aureus (MRSA) causes about 94,000 infections and contributes to 19,000 deaths each year in the United States, according to the U.S. Centers for Disease Control and Prevention.

New drugs are needed to combat such superbugs, but few new antibiotics have been developed in recent decades.

"There are a lot of targets to go after, but people haven't been able to find the drugs," Lu said.

More information

The U.S. Food and Drug Administration has more about antibiotic resistance.



-- Robert Preidt



SOURCE: Massachusetts Institute of Technology, news release, March 2, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers design re-engineered hospital discharge program to reduce rehospitalization
2. Engineered virus targets and kills apparent cancer stem cells in neuroblastoma
3. FDA Issues Final Regulations for Genetically Engineered Animals
4. E. coli engineered to produce important class of antibiotic, anti-cancer drugs
5. Top Athletes Join Forces for a New Mission: Athlete-Engineered Skincare to Support Performance and Benefit Charity
6. FDA Proposes Regulations for Genetically Engineered Animals
7. Tumor suppressor genes speed up and slow down aging in engineered mouse
8. OrbusNeich Receives Approval to Market Genous(TM) Bio-engineered R stent(TM) in Taiwan
9. Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
10. Reconstructing mandibular defects with bioengineered tooth and bone
11. Nanomedicine system engineered to enhance therapeutic effects of injectable drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Engineered Viruses Could Battle Superbugs
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: